Herbert Cooper, MD
Adult Reconstructive Orthopaedic Surgery · New York, NYNPI 1376798850
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.1%), speaking fees and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Zimmer Biomet at 49.3% of the total. Reporting peaked in 2022 at $337,361 and has fallen 50.4% since, to $167,437 in 2025. Among adult reconstructive orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 894 payments — averaging $1462.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$645K
- KCI USA, Inc.$527K
- Solventum Corporation$94K
- Depuy Synthes Products, Inc.$18K
- Polarisar Inc$11K
- Johnson & Johnson$5K
- plus $8K from 9 others
Across 15 payments — averaging $11,666 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$175K
What the payments were for
- Consulting fees$616,52147%
- Speaking & faculty fees$433,28433%
- Travel & lodging$114,9729%
- Food & beverage$16,4071%
- Education$126,66710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 470 | $644,965 |
| KCI USA, Inc. | 326 | $526,791 |
| Solventum Corporation | 42 | $93,989 |
| Depuy Synthes Products, Inc. | 17 | $18,324 |
| Polarisar Inc | 1 | $11,234 |
| Johnson & Johnson(3 entities) | 11 | $4,580 |
| Medical Device Business Services, Inc. | 13 | $3,274 |
| Canary Medical USA LLC | 2 | $3,000 |
| ZOLL Medical Corporation | 1 | $520 |
| Stryker | 3 | $434 |
| Amgen | 4 | $306 |
| Medtronic | 1 | $178 |
| Exactech, Inc. | 1 | $130 |
| Smith+Nephew | 1 | $115 |
| Heraeus Medical, LLC. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PREVENA$557,327
- ROSA$247,429
- Avenir$133,288
- ROSA-Knee$133,035
- PREVENA RESTOR ARTHROFORM$107,427
- V.A.C. VERAFLO$97,551
- G7$94,988
- Arcos$50,053
- Persona$48,621
- PREVENA RESTOR AXIOFORM$46,706
- V.A.C. VERAFLO CLEANSE CHOICE$41,040
- PREVENA RESTOR BELLAFORM$40,798
- Taperloc$34,688
- 3M Cavilon$30,800
- V.A.C. DERMATAC$26,338
- Bair Hugger$26,038
- VAC VERAFLO$25,575
- PROMOGRAN PRISMA$24,413
- PREVENA RESTOR ROTOFORM$21,700
- ACTIS$20,468
How this compares
$1,307,851 in reported general payments places this provider in the 90th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.
See all adult reconstructive orthopaedic surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 12 | $22,814 |
| Celecoxib | 55 | $2,927 |
| CeftriaxoneCeftriaxone Sodium | 11 | $677 |
| Meloxicam | 110 | $304 |
| Oxycodone Hcl | 41 | $172 |
| Tramadol Hcl | 50 | $170 |
| Methylprednisolone | 12 | $111 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in New York
- Seth JerabekNew York$7.1M
- Jose RodriguezNew York$3.4M
- Friedrich BoettnerNew York$2.9M
- Jonathan VigdorchikNew York$2.3M
- William LongNew York$1.5M
- Peter SculcoNew York$1.5M
- Roshan ShahNew York$1.3M
- Matthew AustinNew York$986K
- Patrick MeereNew York$191K
- Eytan DebbiNew York$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.